Monoclonal Anti-Bevacizumab Antibody, Mouse IgG1 (AY12)

製品番号/仕様
価格
Availability
数量
BEB-Y12-100ug
$355.00
In Stock - Delivery in 2-3 business days
BEB-Y12-1mg (500ug X 2)
$2,695.00
In Stock - Delivery in 2-3 business days
BEB-Y12
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Monoclonal Anti-Bevacizumab Antibody, Mouse IgG1 (AY12) (Cat. No. BEB-Y12) is a mouse monoclonal antibody produced from a hybridoma generated by fusion of SP2/0 myeloma cells with mouse B lymphocytes.

Antibody Type

Hybridoma Monoclonal

Clone

AY12

Isotype

Mouse IgG1, Kappa

Host Species

Mouse

Specificity

AY12 is an inhibitory anti-idiotype monoclonal antibody that specifically recognizes Bevacizumab. No detectable binding to the tested human IgG1 controls, VEGF165, Trastuzumab, or Adalimumab was observed under the tested conditions. AY12 inhibits the binding of Bevacizumab to VEGF165.

Application
Application
Recommended Use / Performance
ELISA
11-110 ng/mL
Blocking Elisa
0.12-0.66 μg/mL
ADA Assay Development
Validated as a surrogate positive control in bridging ELISA assays.
(Recommended dilutions are for reference only. Optimal working concentrations may vary depending on your consumables, reagents, and assay conditions. We recommend optimizing for your specific system. No warranty is made regarding performance at any specific dilution.)
Purification

Protein A purified.

Aggregation

Less than 5%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in Tris (pH 7.5) containing 100 mM Glycine, 25 mM Arginine, 150 mM NaCl and 0.01% Tween80, with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

バックグランド

A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.